MindWalk Holdings (HYFT) Invested Capital (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Invested Capital of $2.6 million for Q2 2026, down 73.32% year-over-year from $9.6 million in Q2 2025, and up 1.3% quarter-over-quarter from $2.5 million in Q1 2026.
MindWalk Holdings (HYFT) Invested Capital (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Invested Capital for 7 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Invested Capital fell 73.32% year-over-year to $2.6 million; the TTM figure through Apr 2026 stood at $10.4 million (down 74.71% YoY), while the FY2026 annual figure was $2.6 million, down 73.88% from the prior year.
- Invested Capital climbed to $2.6 million in Q2 2026 per HYFT's latest filing, from $2.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $12.2 million in Q4 2024 and bottomed at $374189.0 in Q4 2022.
- Historically, Invested Capital has averaged $5.8 million across 5 years, with a median of $5.9 million in 2023.
- Annual changes were most pronounced in 2024 — Invested Capital soared 2695.36% — and 2025, when it tumbled 78.65%.
- MindWalk Holdings' Invested Capital stood at $374189.0 in 2022, then soared by 1899.49% to $7.5 million in 2023, then surged by 63.66% to $12.2 million in 2024, then sank by 78.65% to $2.6 million in 2025, then declined by 1.62% to $2.6 million in 2026.
- Business Quant data shows HYFT's Invested Capital at $2.6 million in Q2 2026, $2.5 million in Q1 2026, and $2.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.57 Mn |
| Jan 31, 2026 | 2.54 Mn |
| Oct 31, 2025 | 2.61 Mn |
| Jul 31, 2025 | 2.71 Mn |
| Apr 30, 2025 | 9.64 Mn |
| Jan 31, 2025 | 9.32 Mn |
| Oct 31, 2024 | 12.24 Mn |
| Jul 31, 2024 | 10.07 Mn |
| Apr 30, 2024 | 10.30 Mn |
| Jan 31, 2024 | 11.07 Mn |
| Oct 31, 2023 | 7.48 Mn |
| Jul 31, 2023 | 7.77 Mn |
| Apr 30, 2023 | 5.85 Mn |
| Jan 31, 2023 | 395,904.62 |
| Oct 31, 2022 | 374,189.03 |
| Jul 31, 2022 | 605,693.63 |
| Apr 30, 2022 | 3.16 Mn |
| Apr 30, 2021 | 3.14 Mn |
| Jan 31, 2021 | 779,804.73 |
| Oct 31, 2020 | 5,313.97 |